XML 26 R10.htm IDEA: XBRL DOCUMENT v3.6.0.2
Balance Sheet Account Detail
12 Months Ended
Dec. 31, 2016
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Account Detail
Balance Sheet Account Detail
(a) Property and Equipment
Property and equipment consisted of the following:
 
December 31,
 
2016
 
2015
Production equipment, molds, and office furniture
$
11,714


$
13,603

Computer hardware and software
8,162


6,380

Leasehold improvements
15,495


14,345

Construction in progress (software and related implementation, production equipment, and leasehold improvements)
839


510

Property and equipment, at cost
36,210


34,838

Accumulated depreciation
(12,945
)

(11,483
)
Property and equipment, net
$
23,265


$
23,355


Depreciation expense for property and equipment for the years ended December 31, 2016, 2015, and 2014 was $5.3 million, $4.6 million, and $2.7 million, respectively.

(b) Inventories
Inventories consisted of the following:

December 31,

2016

2015
Raw materials
$
13,133


$
7,701

Work-in-process
10,139


4,355

Finished goods
17,888


15,804

Inventories
$
41,160


$
27,860


(c) Goodwill and Intangible Assets
The following table presents goodwill, indefinite lived intangible assets, finite lived intangible assets, and related accumulated amortization:
 
December 31,
 
2016

2015
Goodwill (1)
$
120,711


$
28,685





Intangible assets:





Indefinite lived intangibles



Trademarks and trade names
$
2,708


$
2,708

In-process research and development (1)
11,200







Finite lived intangibles



Developed technology (1)
$
67,600


$
40,100

Accumulated amortization
(3,810
)

(690
)
 Developed technology, net
$
63,790


$
39,410





Customer relationship (1)
$
7,500


$

Accumulated amortization
(687
)


 Customer relationship, net
$
6,813


$





 Intangible assets (excluding goodwill), net
$
84,511


$
42,118

(1) Difference in the value between these dates is mainly due to acquisition of TriVascular. Refer to Note 13 of the consolidated financial statements for further discussion.
Amortization expense for intangible assets for the years ended December 31, 2016, 2015, and 2014 was $3.8 million, $1.3 million, and $0.6 million, respectively.
Estimated amortization expense for the five succeeding years and thereafter is as follows:

Amortization Expense
2017
$
3,818

2018
4,574

2019
6,036

2020
7,677

2021
8,917

2022 and thereafter
39,581

Total
$
70,603


(d) Marketable securities

Investments in held-to-maturity marketable securities, consist of the following at December 31, 2016 and December 31, 2015:


December 31, 2016


Amortized
Cost

Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value
Agency bonds

$
6,488


$
2

 
$


$
6,490

Corporate bonds

10,513




(21
)

$
10,492

Commercial paper

3,987






3,987

Total

$
20,988


$
2


$
(21
)

$
20,969


 
 
December 31, 2015
 
 
Amortized
Cost
 
Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value
 
 
 
 
 
 
 
 
 
Agency bonds
 
$
8,000

 
$

 
$
(20
)
 
$
7,980

Government securities
 
40,824

 
1

 
(33
)
 
$
40,792

Commercial paper
 
3,944

 

 

 
$
3,944

Total
 
$
52,768

 
$
1

 
$
(53
)
 
$
52,716

At December 31, 2016, the Company’s investments included 5 held-to-maturity debt securities in unrealized loss positions with a total unrealized loss of approximately $21 thousand and a total fair market value of approximately $10.5 million. All investments with gross unrealized losses have been in unrealized loss positions for less than 5 months. The unrealized losses were caused by interest rate fluctuations. There was no change in the credit risk of the securities. The Company does not intend to sell the securities and it is not more likely than not that the Company will be required to sell the securities before the expected recovery of their amortized cost bases. There were no realized gains or losses on the investments for year ended December 31, 2016. Investments of held-to-maturity securities all mature within less than 12 months with an average maturity of 5.0 months.
(e) Fair Value Measurements
The following fair value hierarchy table presents information about each major category of the Company’s assets and liabilities measured at fair value on a recurring basis as of December 31, 2016:


 Fair value measurement at reporting date using:
 

Quoted prices in
active markets for
identical assets
(Level 1)

Significant other
observable
inputs
(Level 2)

Significant
unobservable
inputs
(Level 3)

Total
At December 31, 2016








Cash and cash equivalents

$
26,120


$


$


$
26,120

Restricted cash

$
2,001


$


$


$
2,001

Contingently issuable common stock

$


$


$
12,200


$
12,200

At December 31, 2015












Cash and cash equivalents

$
124,553


$


$


$
124,553

Contingently issuable common stock

$


$


$
14,700


$
14,700



There were no remeasurements to fair value during the years ended December 31, 2016 and 2015 of financial assets and liabilities that are not measured at fair value on a recurring basis. There were no transfers between Level 1, Level 2, or Level 3 securities during the years ended December 31, 2016 and 2015.
(f) Instruments Not Recorded at Fair Value on a Recurring Basis
We measure the fair value of our Senior Notes carried at amortized cost quarterly for disclosure purposes. The estimated fair value of the Senior Notes is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar issues. Based on the market prices, the fair value of our long-term debt was $187.6 million as of December 31, 2016 and $207.9 million as of December 31, 2015.
We measure the fair value of our held-to-maturity marketable securities carried at amortized cost quarterly for disclosure purposes. The fair value of certain marketable securities is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar instruments.